"They’re priced for profits, not patients.” That’s the critique from Hims & Hers Health’s buzzy — and controversial — Super ...

The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...

Telehealth stock Hims & Hers (HIMS) spiked more than 24% in trading Thursday, days after its Super Bowl ad promoting cheaper ...

An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.

Drug industry allies are calling out a Super Bowl ad touting its weight loss medications from telehealth company Hims & Hers ... misleading marketing in health products." The group also requested ...

Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.

The ad promotes, without identifying, semaglutide, the compounded versions of the weight-loss drugs Ozempic ... Companies such as Hims & Hers Health, Ro and Noom use loopholes in the law that ...